Correlation of KIT and PDGFRA mutational status with clinical benefit in patients (pts) with gastrointestinal stromal tumor (GIST) treated with sunitinib (SU) in a worldwide treatment-use (TU) trial
| العنوان: | Correlation of KIT and PDGFRA mutational status with clinical benefit in patients (pts) with gastrointestinal stromal tumor (GIST) treated with sunitinib (SU) in a worldwide treatment-use (TU) trial |
|---|---|
| المؤلفون: | Reichardt, Peter, Demetri, George D., Gelderblom, Hans, Rutkowski, Piotr, Im, Seock-Ah, Gupta, Sudeep, Kang, Yoon-Koo, Schoffski, Patrick, Schuette, Jochen, Soulieres, Denis, Jean-Yves Blay, Goldstein, David, Fly, Kolette D., Huang, Xin, Corsaro, Massimo, Lechuga, Mariajose, Martini, Jean-Francois, Heinrich, Michael C. |
| المصدر: | Journal of Clinical Oncology, 32(15) ResearcherID |
| سنة النشر: | 2014 |
| اللغة: | English |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5a563a873f30a9595c6e35cb79f69b9b http://hdl.handle.net/1887/105132 |
| حقوق: | CLOSED |
| رقم الأكسشن: | edsair.dedup.wf.001..5a563a873f30a9595c6e35cb79f69b9b |
| قاعدة البيانات: | OpenAIRE |
| الوصف غير متاح. |